Randomized Trial Comparing EmbryoScope With EmbryoScope+.
| Status: | Terminated |
|---|---|
| Conditions: | Women's Studies, Infertility |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 2/9/2019 |
| Start Date: | September 6, 2017 |
| End Date: | June 4, 2018 |
Randomized Controlled Trial Comparing EmbryoScope Time-Lapse System With the New Model EmbryoScope+.
The purpose of the study is to compare the current EmbryoScope Time-Lapse System being used
in IVF which has become standard of care to the new model EmbryoScope to demonstrate that the
EmbryoScope+ is as safe and reliable as the EmbryoScope.
in IVF which has become standard of care to the new model EmbryoScope to demonstrate that the
EmbryoScope+ is as safe and reliable as the EmbryoScope.
This is a randomized, controlled, single-center study in otherwise healthy infertile female
subjects undergoing in vitro fertilization (IVF). The subjects recruited for this study will
be among those patients who have been diagnosed with infertility and are planning to undergo
IVF at the center where this study is being performed. The subjects will have undergone the
usual informed consent procedure at the center.
Subjects will undergo ovarian stimulation, oocyte retrieval, IVF, and Intra Cytoplasmic Sperm
Injection (ICSI) procedure following the center's usual procedures. At the time of retrieval,
participant's oocytes will be randomly assigned to both groups for comparison: Standard
EmbryoScope Time-Lapse system versus EmbryoScope+. The best quality embryos are selected for
embryo transfer and the pregnancy outcome is evaluated.
"Best grade" embryos will be transferred regardless of EmbryoScope use. The standard
EmbryoScope as well as the EmbryoScope+ monitor system as assigned during the randomization
process will be used to observe the embryo development and document timing of embryo
cleavages and morphology dynamics. Subjects will not be provided with the time- lapse images.
Endpoints will be Day 3 and Day 5/6 embryo development, implantation and pregnancy rate. The
study is approximately 2 months, the estimated time it takes a physician to perform one
IVF-ART treatment cycle. If embryos are frozen, the patient may be in the study until the
time they choose to thaw the embryos or up to 1 year if they become pregnant.
subjects undergoing in vitro fertilization (IVF). The subjects recruited for this study will
be among those patients who have been diagnosed with infertility and are planning to undergo
IVF at the center where this study is being performed. The subjects will have undergone the
usual informed consent procedure at the center.
Subjects will undergo ovarian stimulation, oocyte retrieval, IVF, and Intra Cytoplasmic Sperm
Injection (ICSI) procedure following the center's usual procedures. At the time of retrieval,
participant's oocytes will be randomly assigned to both groups for comparison: Standard
EmbryoScope Time-Lapse system versus EmbryoScope+. The best quality embryos are selected for
embryo transfer and the pregnancy outcome is evaluated.
"Best grade" embryos will be transferred regardless of EmbryoScope use. The standard
EmbryoScope as well as the EmbryoScope+ monitor system as assigned during the randomization
process will be used to observe the embryo development and document timing of embryo
cleavages and morphology dynamics. Subjects will not be provided with the time- lapse images.
Endpoints will be Day 3 and Day 5/6 embryo development, implantation and pregnancy rate. The
study is approximately 2 months, the estimated time it takes a physician to perform one
IVF-ART treatment cycle. If embryos are frozen, the patient may be in the study until the
time they choose to thaw the embryos or up to 1 year if they become pregnant.
Inclusion Criteria:
- 40 years of age or younger (maternal)
- 65 years of age or younger (paternal)
- Fresh or frozen (including donor) sperm can be used
- Fresh oocytes only (including donor)
- Frozen embryos from this study can be included in the outcome portion of this study.
- Single or double Blastocyst transfer only
Exclusion Criteria:
- 3 or more previous failed cycles
- Sperm obtained by testicular biopsy
- Co-culture patients
We found this trial at
1
site
New York, New York 10065
Principal Investigator: Nikica Zaninovic, PhD
Phone: 646-962-3274
Click here to add this to my saved trials
